News & Updates

The off-label oral solution of misoprostol proves noninferior to the licensed oral tablet for induction of labour, with no significant difference in the occurrence of vaginal delivery within 24 hours, according to a study.

Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.

Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.